Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P E Fraser

Showing results (81-90 of 96) with videos related to

Pageof 10
Sort By:
The Journal of Biological Chemistry|June 17, 2000
Mutation of conserved aspartates affects maturation of both aspartate mutant and endogenous presenilin 1 and presenilin 2 complexesG Yu, F Chen, M Nishimura, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 18, 2010
Islet amyloid deposition limits the viability of human islet grafts but not porcine islet graftsK J Potter, A Abedini, P Marek, et al.
Nature|January 5, 2001
A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's diseaseC Janus, J Pearson, J McLaurin, et al.
Nature Cell Biology|August 3, 2001
Nicastrin binds to membrane-tethered NotchF Chen, G Yu, S Arawaka, et al.
Journal of Neurochemistry|February 26, 1999
Presenilins interact with armadillo proteins including neural-specific plakophilin-related protein and beta-cateninG Levesque, G Yu, M Nishimura, et al.
FEBS Letters|December 31, 1997
Proteolytic processing of presenilin-1 (PS-1) is not associated with Alzheimer's disease with or without PS-1 mutationsM Okochi, K Ishii, M Usami, et al.
Molecular Medicine (Cambridge, Mass.)|December 29, 2000
Brain expression of presenilins in sporadic and early-onset, familial Alzheimer's diseaseP M Mathews, A M Cataldo, B H Kao, et al.
Nature Medicine|October 16, 2002
Therapeutically effective antibodies against amyloid-beta peptide target amyloid-beta residues 4-10 and inhibit cytotoxicity and fibrillogenesisJ McLaurin, R Cecal, M E Kierstead, et al.
Neuroreport|April 14, 1997
Two novel (M233T and R278T) presenilin-1 mutations in early-onset Alzheimer's disease pedigrees and preliminary evidence for association of presenilin-1 mutations with a novel phenotypeJ B Kwok, K Taddei, M Hallupp, et al.
The Journal of Biological Chemistry|August 30, 2000
Carboxyl-terminal fragments of Alzheimer beta-amyloid precursor protein accumulate in restricted and unpredicted intracellular compartments in presenilin 1-deficient cellsF Chen, D S Yang, S Petanceska, et al.
Pageof 10

Showing results (81-90 of 96) with videos related to

Sort By:
Pageof 10
The Journal of Biological Chemistry|June 17, 2000
Mutation of conserved aspartates affects maturation of both aspartate mutant and endogenous presenilin 1 and presenilin 2 complexesG Yu, F Chen, M Nishimura, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 18, 2010
Islet amyloid deposition limits the viability of human islet grafts but not porcine islet graftsK J Potter, A Abedini, P Marek, et al.
Nature|January 5, 2001
A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's diseaseC Janus, J Pearson, J McLaurin, et al.
Nature Cell Biology|August 3, 2001
Nicastrin binds to membrane-tethered NotchF Chen, G Yu, S Arawaka, et al.
Journal of Neurochemistry|February 26, 1999
Presenilins interact with armadillo proteins including neural-specific plakophilin-related protein and beta-cateninG Levesque, G Yu, M Nishimura, et al.
FEBS Letters|December 31, 1997
Proteolytic processing of presenilin-1 (PS-1) is not associated with Alzheimer's disease with or without PS-1 mutationsM Okochi, K Ishii, M Usami, et al.
Molecular Medicine (Cambridge, Mass.)|December 29, 2000
Brain expression of presenilins in sporadic and early-onset, familial Alzheimer's diseaseP M Mathews, A M Cataldo, B H Kao, et al.
Nature Medicine|October 16, 2002
Therapeutically effective antibodies against amyloid-beta peptide target amyloid-beta residues 4-10 and inhibit cytotoxicity and fibrillogenesisJ McLaurin, R Cecal, M E Kierstead, et al.
Neuroreport|April 14, 1997
Two novel (M233T and R278T) presenilin-1 mutations in early-onset Alzheimer's disease pedigrees and preliminary evidence for association of presenilin-1 mutations with a novel phenotypeJ B Kwok, K Taddei, M Hallupp, et al.
The Journal of Biological Chemistry|August 30, 2000
Carboxyl-terminal fragments of Alzheimer beta-amyloid precursor protein accumulate in restricted and unpredicted intracellular compartments in presenilin 1-deficient cellsF Chen, D S Yang, S Petanceska, et al.
Pageof 10